Back

Impact of cardiometabolic index on cardiovascular-kidney-metabolic syndrome stage progression: a nationwide prospective cohort study

29 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (1) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Shuang Wu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

7 More presentations in this session

Presentation thumbnail
Comparison of nutritional risk scores for predicting cardiovascular morbidity and mortality in incident haemodialysis patients
Assistant Professor H. Takahashi (Toyoake, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular disease burden attributable to decreased estimated glomerular filtration rate: insights from the ATTICA study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction
Doctor P. Tonnesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Associations of metabolic vulnerability index with cardiometabolic diseases, multimorbidity, and all-cause mortality
Doctor S. Zhu (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Blood pressure, glycemic, and cholesterol control among adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2023
Doctor J. Gong (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome in korean: a nationwide stage-specific epidemiology and risk of major adverse cardiovascular events
thumbnail
Congress Session
Metabolic drivers of cardiovascular disease
thumbnail
Congress Presentation
Dietary inflammatory index in progression and mortality risk of cardiovascular-kidney-metabolic syndrome: NHANES 1999-2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources